The global Novel Drug Delivery Systems market size is predicted to grow from US$ 24960 million in 2025 to US$ 27720 million in 2031; it is expected to grow at a CAGR of 1.8% from 2025 to 2031.
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
Global Novel Drug Delivery Systems key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share over 40%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%. And in terms of application, the largest application is Hospitals & Clinic, followed by Cancer Treatment Centers, etc.
The “Novel Drug Delivery Systems Industry Forecast” looks at past sales and reviews total world Novel Drug Delivery Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected Novel Drug Delivery Systems sales for 2025 through 2031. With Novel Drug Delivery Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Novel Drug Delivery Systems industry.
This Insight Report provides a comprehensive analysis of the global Novel Drug Delivery Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Novel Drug Delivery Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Novel Drug Delivery Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Novel Drug Delivery Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Novel Drug Delivery Systems.
This report presents a comprehensive overview, market shares, and growth opportunities of Novel Drug Delivery Systems market by product type, application, key players and key regions and countries.
Segmentation by Type:
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Segmentation by Application:
Hospitals & Clinic
Cancer Treatment Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Novel Drug Delivery Systems Market Size (2020-2031)
2.1.2 Novel Drug Delivery Systems Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Novel Drug Delivery Systems by Country/Region (2020, 2024 & 2031)
2.2 Novel Drug Delivery Systems Segment by Type
2.2.1 Liposomes
2.2.2 PEGylated Proteins & Polypeptides
2.2.3 Polymer Nanoparticle
2.2.4 Protein–drug Conjugates
2.2.5 Others
2.3 Novel Drug Delivery Systems Market Size by Type
2.3.1 Novel Drug Delivery Systems Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Novel Drug Delivery Systems Market Size Market Share by Type (2020-2025)
2.4 Novel Drug Delivery Systems Segment by Application
2.4.1 Hospitals & Clinic
2.4.2 Cancer Treatment Centers
2.4.3 Others
2.5 Novel Drug Delivery Systems Market Size by Application
2.5.1 Novel Drug Delivery Systems Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Novel Drug Delivery Systems Market Size Market Share by Application (2020-2025)
3 Novel Drug Delivery Systems Market Size by Player
3.1 Novel Drug Delivery Systems Market Size Market Share by Player
3.1.1 Global Novel Drug Delivery Systems Revenue by Player (2020-2025)
3.1.2 Global Novel Drug Delivery Systems Revenue Market Share by Player (2020-2025)
3.2 Global Novel Drug Delivery Systems Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Novel Drug Delivery Systems by Region
4.1 Novel Drug Delivery Systems Market Size by Region (2020-2025)
4.2 Global Novel Drug Delivery Systems Annual Revenue by Country/Region (2020-2025)
4.3 Americas Novel Drug Delivery Systems Market Size Growth (2020-2025)
4.4 APAC Novel Drug Delivery Systems Market Size Growth (2020-2025)
4.5 Europe Novel Drug Delivery Systems Market Size Growth (2020-2025)
4.6 Middle East & Africa Novel Drug Delivery Systems Market Size Growth (2020-2025)
5 Americas
5.1 Americas Novel Drug Delivery Systems Market Size by Country (2020-2025)
5.2 Americas Novel Drug Delivery Systems Market Size by Type (2020-2025)
5.3 Americas Novel Drug Delivery Systems Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Novel Drug Delivery Systems Market Size by Region (2020-2025)
6.2 APAC Novel Drug Delivery Systems Market Size by Type (2020-2025)
6.3 APAC Novel Drug Delivery Systems Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Novel Drug Delivery Systems Market Size by Country (2020-2025)
7.2 Europe Novel Drug Delivery Systems Market Size by Type (2020-2025)
7.3 Europe Novel Drug Delivery Systems Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Novel Drug Delivery Systems by Region (2020-2025)
8.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2020-2025)
8.3 Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Novel Drug Delivery Systems Market Forecast
10.1 Global Novel Drug Delivery Systems Forecast by Region (2026-2031)
10.1.1 Global Novel Drug Delivery Systems Forecast by Region (2026-2031)
10.1.2 Americas Novel Drug Delivery Systems Forecast
10.1.3 APAC Novel Drug Delivery Systems Forecast
10.1.4 Europe Novel Drug Delivery Systems Forecast
10.1.5 Middle East & Africa Novel Drug Delivery Systems Forecast
10.2 Americas Novel Drug Delivery Systems Forecast by Country (2026-2031)
10.2.1 United States Market Novel Drug Delivery Systems Forecast
10.2.2 Canada Market Novel Drug Delivery Systems Forecast
10.2.3 Mexico Market Novel Drug Delivery Systems Forecast
10.2.4 Brazil Market Novel Drug Delivery Systems Forecast
10.3 APAC Novel Drug Delivery Systems Forecast by Region (2026-2031)
10.3.1 China Novel Drug Delivery Systems Market Forecast
10.3.2 Japan Market Novel Drug Delivery Systems Forecast
10.3.3 Korea Market Novel Drug Delivery Systems Forecast
10.3.4 Southeast Asia Market Novel Drug Delivery Systems Forecast
10.3.5 India Market Novel Drug Delivery Systems Forecast
10.3.6 Australia Market Novel Drug Delivery Systems Forecast
10.4 Europe Novel Drug Delivery Systems Forecast by Country (2026-2031)
10.4.1 Germany Market Novel Drug Delivery Systems Forecast
10.4.2 France Market Novel Drug Delivery Systems Forecast
10.4.3 UK Market Novel Drug Delivery Systems Forecast
10.4.4 Italy Market Novel Drug Delivery Systems Forecast
10.4.5 Russia Market Novel Drug Delivery Systems Forecast
10.5 Middle East & Africa Novel Drug Delivery Systems Forecast by Region (2026-2031)
10.5.1 Egypt Market Novel Drug Delivery Systems Forecast
10.5.2 South Africa Market Novel Drug Delivery Systems Forecast
10.5.3 Israel Market Novel Drug Delivery Systems Forecast
10.5.4 Turkey Market Novel Drug Delivery Systems Forecast
10.6 Global Novel Drug Delivery Systems Forecast by Type (2026-2031)
10.7 Global Novel Drug Delivery Systems Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Novel Drug Delivery Systems Forecast
11 Key Players Analysis
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Novel Drug Delivery Systems Product Offered
11.1.3 Amgen Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Novel Drug Delivery Systems Product Offered
11.2.3 Teva Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Novel Drug Delivery Systems Product Offered
11.3.3 Roche Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 UCB (Union Chimique Belge)
11.4.1 UCB (Union Chimique Belge) Company Information
11.4.2 UCB (Union Chimique Belge) Novel Drug Delivery Systems Product Offered
11.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 UCB (Union Chimique Belge) Main Business Overview
11.4.5 UCB (Union Chimique Belge) Latest Developments
11.5 Celgene
11.5.1 Celgene Company Information
11.5.2 Celgene Novel Drug Delivery Systems Product Offered
11.5.3 Celgene Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Celgene Main Business Overview
11.5.5 Celgene Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Novel Drug Delivery Systems Product Offered
11.6.3 Merck Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Information
11.7.2 Gilead Sciences Novel Drug Delivery Systems Product Offered
11.7.3 Gilead Sciences Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Gilead Sciences Main Business Overview
11.7.5 Gilead Sciences Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Novel Drug Delivery Systems Product Offered
11.8.3 Sanofi Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Novel Drug Delivery Systems Product Offered
11.9.3 Pfizer Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Novel Drug Delivery Systems Product Offered
11.10.3 Takeda Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Bausch&Lomb
11.11.1 Bausch&Lomb Company Information
11.11.2 Bausch&Lomb Novel Drug Delivery Systems Product Offered
11.11.3 Bausch&Lomb Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Bausch&Lomb Main Business Overview
11.11.5 Bausch&Lomb Latest Developments
11.12 Samyang Biopharmaceuticals
11.12.1 Samyang Biopharmaceuticals Company Information
11.12.2 Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Offered
11.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Samyang Biopharmaceuticals Main Business Overview
11.12.5 Samyang Biopharmaceuticals Latest Developments
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Information
11.13.2 Johnson & Johnson Novel Drug Delivery Systems Product Offered
11.13.3 Johnson & Johnson Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Johnson & Johnson Main Business Overview
11.13.5 Johnson & Johnson Latest Developments
11.14 TOLMAR
11.14.1 TOLMAR Company Information
11.14.2 TOLMAR Novel Drug Delivery Systems Product Offered
11.14.3 TOLMAR Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 TOLMAR Main Business Overview
11.14.5 TOLMAR Latest Developments
11.15 Astellas
11.15.1 Astellas Company Information
11.15.2 Astellas Novel Drug Delivery Systems Product Offered
11.15.3 Astellas Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Astellas Main Business Overview
11.15.5 Astellas Latest Developments
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Information
11.16.2 AMAG Pharmaceuticals Novel Drug Delivery Systems Product Offered
11.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 AMAG Pharmaceuticals Main Business Overview
11.16.5 AMAG Pharmaceuticals Latest Developments
11.17 AbbVie
11.17.1 AbbVie Company Information
11.17.2 AbbVie Novel Drug Delivery Systems Product Offered
11.17.3 AbbVie Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 AbbVie Main Business Overview
11.17.5 AbbVie Latest Developments
11.18 Dr Reddy
11.18.1 Dr Reddy Company Information
11.18.2 Dr Reddy Novel Drug Delivery Systems Product Offered
11.18.3 Dr Reddy Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Dr Reddy Main Business Overview
11.18.5 Dr Reddy Latest Developments
11.19 AstraZeneca
11.19.1 AstraZeneca Company Information
11.19.2 AstraZeneca Novel Drug Delivery Systems Product Offered
11.19.3 AstraZeneca Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 AstraZeneca Main Business Overview
11.19.5 AstraZeneca Latest Developments
11.20 Aspen
11.20.1 Aspen Company Information
11.20.2 Aspen Novel Drug Delivery Systems Product Offered
11.20.3 Aspen Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Aspen Main Business Overview
11.20.5 Aspen Latest Developments
11.21 Acrotech Biopharma
11.21.1 Acrotech Biopharma Company Information
11.21.2 Acrotech Biopharma Novel Drug Delivery Systems Product Offered
11.21.3 Acrotech Biopharma Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Acrotech Biopharma Main Business Overview
11.21.5 Acrotech Biopharma Latest Developments
11.22 TWi Pharmaceuticals
11.22.1 TWi Pharmaceuticals Company Information
11.22.2 TWi Pharmaceuticals Novel Drug Delivery Systems Product Offered
11.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 TWi Pharmaceuticals Main Business Overview
11.22.5 TWi Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Ěý
Ěý
*If Applicable.
